| |
| |
|
| Insider
Information: |
Nanavaty Maulik |
| Relationship: |
|
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
177,758 |
|
|
Indirect Shares
|
11,017 |
|
|
| Direct
Value |
$13,406,023 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
188,775 |
|
|
| Total
Value |
$13,406,023 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 6.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
SVP & Pres, Neuromodul... |
2022-02-28 |
177,258 |
|
0 |
Premium* |
|
|
Rani Therapeutics Holdings, Inc. |
RANI |
|
2023-11-16 |
500 |
2023-11-16 |
11,017 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-02-09 |
4 |
OE |
$12.52 |
$194,911 |
D/D |
15,568 |
229,757 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2016-02-22 |
4 |
D |
$17.26 |
$219,426 |
D/D |
(12,713) |
167,893 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-08-31 |
4 |
OE |
$7.39 |
$222,100 |
D/D |
30,000 |
238,233 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-01-03 |
4 |
AS |
$44.73 |
$224,757 |
D/D |
(5,025) |
255,194 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-08-30 |
4 |
OE |
$6.28 |
$243,455 |
D/D |
27,031 |
235,264 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-08-29 |
4 |
OE |
$7.39 |
$251,519 |
D/D |
34,035 |
289,229 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-14 |
4 |
D |
$42.31 |
$266,553 |
D/D |
(6,300) |
262,334 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-02-28 |
4 |
D |
$24.55 |
$315,026 |
D/D |
(12,832) |
207,091 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-02-20 |
4 |
D |
$40.11 |
$319,235 |
D/D |
(7,959) |
252,123 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-11-27 |
4 |
OE |
$17.26 |
$354,728 |
D/D |
20,552 |
275,746 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-10-03 |
4 |
AS |
$39.25 |
$377,744 |
D/D |
(9,623) |
255,194 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-02-09 |
4 |
S |
$25.38 |
$395,113 |
D/D |
(15,568) |
214,189 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-11-04 |
4 |
AS |
$41.66 |
$400,894 |
D/D |
(9,623) |
255,194 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-02-03 |
4 |
AS |
$42.17 |
$405,802 |
D/D |
(9,623) |
255,194 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-12-04 |
4 |
AS |
$42.89 |
$412,712 |
D/D |
(9,623) |
255,194 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-01-02 |
4 |
AS |
$45.33 |
$436,214 |
D/D |
(9,623) |
260,219 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-05-29 |
4 |
OE |
$6.28 |
$493,794 |
D/D |
71,558 |
206,092 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-03-02 |
4 |
AS |
$37.47 |
$628,183 |
D/D |
(16,763) |
259,591 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-08-30 |
4 |
S |
$27.08 |
$732,083 |
D/D |
(27,031) |
208,233 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2017-08-31 |
4 |
S |
$27.45 |
$823,539 |
D/D |
(30,000) |
208,233 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2018-11-16 |
4 |
S |
$37.28 |
$874,446 |
D/D |
(23,458) |
233,351 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-11-27 |
4 |
S |
$43.27 |
$889,322 |
D/D |
(20,552) |
255,194 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2015-05-29 |
4 |
S |
$18.52 |
$1,325,283 |
D/D |
(71,558) |
134,534 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2019-08-29 |
4 |
S |
$42.65 |
$1,451,423 |
D/D |
(34,035) |
255,194 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Neuromodulation |
• • – |
2020-08-28 |
4 |
S |
$40.45 |
$1,537,165 |
D/D |
(38,000) |
228,993 |
0 |
% |
|
176 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
